ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (ARWR)
CUSIP: 04280A100
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 135,488,140
- Total 13F shares
- 103,362,113
- Share change
- +3,680,991
- Total reported value
- $1,318,228,654
- Put/Call ratio
- 141%
- Price per share
- $12.74
- Number of holders
- 258
- Value change
- +$23,656,546
- Number of buys
- 125
- Number of sells
- 126
Quarterly Holders Quick Answers
What is CUSIP 04280A100?
CUSIP 04280A100 identifies ARWR - ARROWHEAD PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 04280A100:
Institutional Holders of ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (ARWR) as of Q1 2025
As of 31 Mar 2025,
ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (ARWR) was held by
258 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
103,362,113 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, Avoro Capital Advisors LLC, STATE STREET CORP, Slate Path Capital LP, UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC, FMR LLC, GEODE CAPITAL MANAGEMENT, LLC, Siren, L.L.C., and T. Rowe Price Investment Management, Inc..
This page lists
260
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
267
Q1 2025 holders
258
Holder diff
-9
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.